1998
DOI: 10.1038/bjc.1998.259
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of p53, p16MTS1, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines

Abstract: Summary Exposure to aromatic amines is considered a major risk factor for the development of bladder cancer. In this study, we have analysed the pattern of point mutations in several tumour genes in 21 cases of bladder cancer arising among western European workers exposed to aromatic amines in an attempt to determine whether this exposure may be associated with a unique spectrum of mutations. Of the four genes analysed (p53, p16mTs1, p21WAF1 and H-ras), only p53 showed a high frequency of mutations (in 8 out o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(10 citation statements)
references
References 34 publications
1
9
0
Order By: Relevance
“…Yasunaga and coworkers [Yasunaga et al, 1997] described a peculiar TP53 mutation spectrum in bladder tumors from exposed workers with predominantly C to T transitions and a hot spot at codons 151-152, features not found in tumors from people not exposed to aromatic amines. However, in other studies the type (majority G:C to A:T) or distribution of TP53 mutations in occupational bladder cancers has not differed from other bladder cancers suggesting that the etiology is common in both groups or that TP53 mutation is a late event and not related to etiology [Esteve et al, 1995;Taylor et al, 1996;Sorlie et al, 1998]. Increased odds ratios for p53 nuclear over-expression were found by Zhang and coworkers [Zhang et al, 1994] in bladder cancers from workers in dye-and cooking-associated occupations, but the association with cigarette smoking was much stronger.…”
Section: Aromatic Aminesmentioning
confidence: 95%
See 1 more Smart Citation
“…Yasunaga and coworkers [Yasunaga et al, 1997] described a peculiar TP53 mutation spectrum in bladder tumors from exposed workers with predominantly C to T transitions and a hot spot at codons 151-152, features not found in tumors from people not exposed to aromatic amines. However, in other studies the type (majority G:C to A:T) or distribution of TP53 mutations in occupational bladder cancers has not differed from other bladder cancers suggesting that the etiology is common in both groups or that TP53 mutation is a late event and not related to etiology [Esteve et al, 1995;Taylor et al, 1996;Sorlie et al, 1998]. Increased odds ratios for p53 nuclear over-expression were found by Zhang and coworkers [Zhang et al, 1994] in bladder cancers from workers in dye-and cooking-associated occupations, but the association with cigarette smoking was much stronger.…”
Section: Aromatic Aminesmentioning
confidence: 95%
“…These carcinogens pose an increased risk to bladder cancer in the dye/ink industry [Sorlie et al, 1998]. Another important known risk factor for bladder cancer is smoking.…”
Section: Aromatic Aminesmentioning
confidence: 99%
“…Loss of p21 WAF1 expression has been reported as a significant and independent predictor of bladder cancer progression 4,5 . Functional loss of p21 WAF1 through genetic changes such as mutation is rare in bladder cancer 6,7 . Thus it is postulated that epigenetic events such as DNA methylation and histone deacetylation may account for p21 WAF1 loss in bladder cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Alteration of the p53 tumor-suppressor gene is an important indicator of late progression events, with a close relationship to genetic instability (Yamamoto et al, 1997). The majority of studies have demonstrated involvement of ras oncogenes in human bladder carcinogenesis as an early event (Sorlie et al, 1998). It has been indicated that inflammatory mediators, such as numerous cytokines and growth factors, can activate H-ras, an important component in their growth-promoting signaling pathways (Shibayama et al, 1999).…”
mentioning
confidence: 99%